Efficacy of antipsychotics for irritability and aggression in children: a meta-analysis

References

• Foster EM, Jones DE. The high costs of aggression: public expenditures resulting from conduct disorder. Am J Public Health. 2005;95:1767–1772.
   PubMed Web of Science ®Google Scholar
• Malone R. A double-blind placebo-controlled study of lithium in hospitalized aggressive children and adolescents with conduct disorder. Arch Gen Psychiatry. 2000;57(7):649–654.
   PubMed Web of Science ®Google Scholar
• Frick PJ, Lahey BB, Loeber R, et al. Oppositional defiant disorder and conduct disorder: a meta-analytic review of factor analyses and cross-validation in a clinic sample. Clin Psychol Rev. 1993;13:319–340.
   Web of Science ®Google Scholar
• Buitelaar JK, Van der Gaag RJ, Cohen-Kettenis P, et al. A randomized controlled trial of risperidone in the treatment of aggression in hospitalized adolescents with subaverage cognitive abilities. J Clin Psychiatry. 2001;62:239–248.
   PubMed Web of Science ®Google Scholar
• Findling RL, Mankoski R, Timko K, et al. A randomized controlled trial investigating the safety and efficacy of aripiprazole in the long-term maintenance treatment of pediatric patients with irritability associated with autistic disorder. J Clin Psychiatry. 2014;75:22–30.
   PubMed Web of Science ®Google Scholar
• Owen R, Sikich L, Marcus RN, et al. Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder. Pediatrics. 2009;124:1533–1540.
   PubMed Web of Science ®Google Scholar
• Shea S. Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders. Pediatrics. 2004;114:e634–41.
   PubMed Web of Science ®Google Scholar
• Harty SC, Miller CJ, Newcorn JH, et al. Adolescents with childhood ADHD and comorbid disruptive behavior disorders: aggression, anger, and hostility. Child Psychiatry Hum Dev. 2009;40:85–97.
   PubMed Web of Science ®Google Scholar
• Loeber R, Burke JD, Lahey BB, et al. Oppositional defiant and conduct disorder: a review of the past 10 years, part I. J Am Acad Child Adolesc Psychiatry. 2000;39:1468–1484.
   PubMed Web of Science ®Google Scholar
• Dodge KA, Pettit GS. A biopsychosocial model of the development of chronic conduct problems in adolescence. Dev Psychol. 2003;39:349–371.
   PubMed Web of Science ®Google Scholar
• Scott S. Aggressive behaviour in childhood. Br Med J. 1998;316:202–206.
   PubMed Web of Science ®Google Scholar
• Elliot DS. Serious violent offenders: onset, developmental course, and termination. The American Society of Criminology 1993 presidential address. Criminology. 1994;32:1–21.
   Web of Science ®Google Scholar
• Valois RF, MacDonald JM, Bretous L, et al. Risk factors and behaviors associated with adolescent violence and aggression. Am J Health Behav. 2002;26:454–464.
   PubMed Web of Science ®Google Scholar
• Robins LN. Sturdy childhood predictors of adult antisocial behaviour: replications from longitudinal studies. Psychol Med. 1978;8:611–622.
   PubMed Web of Science ®Google Scholar
• Mankoski R, Zhao J, Carson WH, et al. Young mania rating scale line item analysis in pediatric subjects with bipolar I disorder treated with aripiprazole in a short-term, double-blind, randomized study. J Child Adolesc Psychopharmacol. 2011;21:359–364.
   PubMed Web of Science ®Google Scholar
• Nelson RJ, Trainor BC. Neural mechanisms of aggression. Nat Rev Neurosci. 2007;8:536–546.
   PubMed Web of Science ®Google Scholar
• King BH. Pharmacological treatment of mood disturbances, aggression, and self-injury in persons with pervasive developmental disorders. J Autism Dev Disord. 2000;30:439–445.
   PubMed Web of Science ®Google Scholar
• Parikh MS, Kolevzon A, Hollander E. Psychopharmacology of aggression in children and adolescents with autism: a critical review of efficacy and tolerability. J Child Adolesc Psychopharmacol. 2008;18:157–178.
   PubMed Web of Science ®Google Scholar
• Aleman A, Kahn RS. Effects of the atypical antipsychotic risperidone on hostility and aggression in schizophrenia: a meta-analysis of controlled trials. Eur Neuropsychopharmacology. 2001;11:289–293.
   PubMed Web of Science ®Google Scholar
• Matson JL, Jang J. Treating aggression in persons with autism spectrum disorders: a review. Res Dev Disabil. 2014;35:3386–3391.
   PubMed Web of Science ®Google Scholar
• Miller DD. Atypical antipsychotics: sleep, sedation, and efficacy. Prim Care Companion J Clin Psychiatry. 2004;6:3–7.
   PubMedGoogle Scholar
• Picciotto MR, Lewis AS, van Schalkwyk GI, et al. Mood and anxiety regulation by nicotinic acetylcholine receptors: a potential pathway to modulate aggression and related behavioral states. Neuropharmacology. 2015;96:235–243.
   PubMed Web of Science ®Google Scholar
• van Schalkwyk GI, Lewis AS, Qayyum Z, et al. Reduction of aggressive episodes after repeated transdermal nicotine administration in a hospitalized adolescent with autism spectrum disorder. J Autism Dev Disord. 2015;45:3061–3066.
   PubMed Web of Science ®Google Scholar
• Lewis AS, Mineur YS, Smith PH, et al. Modulation of aggressive behavior in mice by nicotinic receptor subtypes. Biochem Pharmacol. 2015;97:488–497.
   PubMed Web of Science ®Google Scholar
• Aman MG, Singh NN, Stewart AW, et al. Psychometric characteristics of the aberrant behavior checklist. Am J Ment Defic. 1985;89:492–502.
   PubMedGoogle Scholar
• Aman MG, De Smedt G, Derivan A, et al. Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence. Am J Psychiatry. 2002;159:1337–1346.
   PubMed Web of Science ®Google Scholar
• Hollander E, Wasserman S, Swanson EN, et al. A double-blind placebo-controlled pilot study of olanzapine in childhood/adolescent pervasive developmental disorder. J Adolesc Psychopharmacol. 2006;16:541–548.
   PubMed Web of Science ®Google Scholar
• Sharma A, Shaw RS. Efficacy of risperidone in managing maladaptive behaviors for children with autistic spectrum disorder: a meta-analysis. J Pediatr Healthc. 2012;26:291–299.
   PubMed Web of Science ®Google Scholar
• Pappadopulos E, Woolston S, Chait A, et al. Pharmacotherapy of aggression in children and adolescents: efficacy and effect size. J Can Acad Child Adolesc Psychiatry. 2006;15(1):27–39.
   Google Scholar
• Yudofsky SC, Silver JM, Jackson W, et al. The overt aggression scale for the objective rating of verbal and physical aggression. Am J Psychiatry. 1986;143:35–39.
   PubMed Web of Science ®Google Scholar
• Connor DF, McLaughlin TJ, Jeffers-Terry M. Randomized controlled pilot study of quetiapine in the treatment of adolescent conduct disorder. J Child Adolesc Psychopharmacol. 2008;18:140–156.
   PubMed Web of Science ®Google Scholar
• Biostat. Comprehensive meta-analysis. 2016.
   Google Scholar
• Woods SW. Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry. 2003;64:663–667.
   PubMed Web of Science ®Google Scholar
• Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009;62:e1–34.
   PubMed Web of Science ®Google Scholar
• Aman MG, Bukstein OG, Gadow KD, et al. What does risperidone add to parent training and stimulant for severe aggression in child attention-deficit/hyperactivity disorder? J Am Acad Adolesc Psychiatry. 2014;53:47–60.
   PubMed Web of Science ®Google Scholar
• Armenteros JL, Lewis JE, Davalos M. Risperidone augmentation for treatment-resistant aggression in attention-deficit/hyperactivity disorder: a placebo-controlled pilot study. J Am Acad Child Adolesc Psychiatry. 2007;46:558–565.
   PubMed Web of Science ®Google Scholar
• Findling RL, McNamara NK, Branicky LA, et al. A double-blind pilot study of risperidone in the treatment of conduct disorder. J Am Acad Adolesc Psychiatry. 2000;39:509–516.
   PubMed Web of Science ®Google Scholar
• Marcus RN, Owen R, Kamen L, et al. A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder. J Am Acad Child Adolesc Psychiatry. 2009;48:1110–1119.
   PubMed Web of Science ®Google Scholar
• Snyder R, Turgay A, Aman M, et al. Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQs. J Am Acad. 2002;41:1026–1036.
   Web of Science ®Google Scholar
• Van Bellinghen M, De Troch C. Risperidone in the treatment of behavioral disturbances in children and adolescents with borderline intellectual functioning: a double-blind, placebo-controlled pilot trial. J Child Adolesc Psychopharmacol. 2001;11:5–13.
   PubMed Web of Science ®Google Scholar
• McCracken JT, McGough J, Shah B, et al. Risperidone in children with autism and serious behavioral problems. N Engl J Med. 2002;347:314–321.
   PubMed Web of Science ®Google Scholar
• Volavka J, Czobor P, Nolan K, et al. Overt aggression and psychotic symptoms in patients with schizophrenia treated with clozapine, olanzapine, risperidone, or haloperidol. J Clin Psychopharmacol. 2004;24:225–228.
   PubMed Web of Science ®Google Scholar
• Aman MG, Tassé MJ, Rojahn J, et al. The Nisonger CBRF: a child behavior rating form for children with developmental disabilities. Res Dev Disabil. 1996;17:41–57.
   PubMed Web of Science ®Google Scholar
• Patel NC, Crismon ML, Hoagwood K, et al. Unanswered questions regarding atypical antipsychotic use in aggressive children and adolescents. J Child Adolesc Psychopharmacol. 2005;15:270–284.
   PubMed Web of Science ®Google Scholar
• Halperin JM, McKay KE, Newcorn JH. Development, reliability, and validity of the children’s aggression scale-parent version. J Am Acad Adolesc Psychiatry. 2002;41:245–252.
   PubMed Web of Science ®Google Scholar
• Narusyte J, Andershed A-K, Neiderhiser JM, et al. Aggression as a mediator of genetic contributions to the association between negative parent–child relationships and adolescent antisocial behavior. Eur Child Adolesc Psychiatry. 2007;16:128–137.
   PubMed Web of Science ®Google Scholar
• Kuperman S, Calarge C, Kolar A, et al. An open-label trial of aripiprazole in the treatment of aggression in male adolescents diagnosed with conduct disorder. Ann Clin Psychiatry. 2011;23:270–276.
   PubMed Web of Science ®Google Scholar
• Achenbach TM, Ruffle TM. The Child Behavior Checklist and related forms for assessing behavioral/emotional problems and competencies. Pediatrics Rev. 2000;21:265–271.
   PubMedGoogle Scholar
• Greenbaum PE, Dedrick RF. Hierarchical confirmatory factor analysis of the Child Behavior Checklist/4-18. Psychol Assess. 1998;10:149–150.
   Web of Science ®Google Scholar
• Henry D, Guerra N, Huesmann R, et al. Normative influences on aggression in urban elementary school classrooms. Am J Community Psychol. 2000;28:59–81.
   PubMed Web of Science ®Google Scholar
• Frye MA, Eudicone J, Pikalov A, et al. Aripiprazole efficacy in irritability and disruptive-aggressive symptoms: young mania rating scale line analysis from two, randomized, double-blind, placebo-controlled trials. J Clin Psychopharmacol. 2008;28:243–245.
   PubMed Web of Science ®Google Scholar
• Hellings J, Weckbaugh M, Nickel EJ, et al. A double-blind, placebo-controlled study of valproate for aggression in youth with pervasive developmental disorders. J Child Adolesc Psychopharmacol. 2005;15:682–692.
   PubMed Web of Science ®Google Scholar
• Aman MG, Singh NN, Stewart AW, et al. The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects. Am J Ment Defic. 1985;89:485–491.
   PubMedGoogle Scholar
• Martin A, Koenig K, Scahill L, et al. Open-label quetiapine in the treatment of children and adolescents with autistic disorder. J Child Adolesc Psychopharmacol. 1999;9:99–107.
   PubMed Web of Science ®Google Scholar
• Findling RL, McNamara NK, Gracious BL, et al. Quetiapine in nine youths with autistic disorder. J Child Adolesc Psychopharmacol. 2004;14:287–294.
   PubMed Web of Science ®Google Scholar
• Findling RL, Reed MD, O’Riordan MA, et al. A 26-week open-label study of quetiapine in children with conduct disorder. J Child Adolesc Psychopharmacol. 2007;17:1–9.
   PubMed Web of Science ®Google Scholar
• Masi G, Milone A, Canepa G, et al. Olanzapine treatment in adolescents with severe conduct disorder. Eur Psychiatry. 2006;21:51–57.
   PubMed Web of Science ®Google Scholar
• Potenza MN, Holmes JP, Kanes SJ, et al. Olanzapine treatment of children, adolescents, and adults with pervasive developmental disorders: an open-label pilot study. J Clin Psychopharmacol. 1999;19:37–44.
   PubMed Web of Science ®Google Scholar
• Stephens RJ, Bassel C, Sandor P. Olanzapine in the treatment of aggression and tics in children with Tourette’s syndrome – a pilot study. J Child Adolesc Psychopharmacol. 2004;14:255–266.
   PubMed Web of Science ®Google Scholar
• Bennett DS, Gibbons TA. Efficacy of child cognitive-behavioral interventions for antisocial behavior: a meta-analysis. Child Fam Behav Ther. 2000;22:1–15.
   Web of Science ®Google Scholar
• Eyberg SM, Nelson MM, Boggs SR. Evidence-based psychosocial treatments for children and adolescents with disruptive behavior. J Clin Adolesc Psychol. 2008;37:215–237.
   PubMed Web of Science ®Google Scholar
• Sukhodolsky DG, Kassinove H, Gorman BS. Cognitive-behavioral therapy for anger in children and adolescents: a meta-analysis. Aggress Violent Behav. 2004;9:247–269.
   Web of Science ®Google Scholar
• Jensen PS, Youngstrom EA, Steiner H, et al. Consensus report on impulsive aggression as a symptom across diagnostic categories in child psychiatry: implications for medication studies. J Am Acad Child Adolesc Psychiatry. 2007;46:309–322.
   PubMed Web of Science ®Google Scholar
• Pappadopulos E, Macintyre Ii JC, Crismon ML, et al. Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part II. J Am Acad Adolesc Psychiatry. 2003;42:145–161.
   PubMed Web of Science ®Google Scholar
• da Fragoso VMS, Hoppe LY, de Araújo-Jorge TC, et al. Use of haloperidol and risperidone in highly aggressive Swiss Webster mice by applying the model of spontaneous aggression (MSA). Behav Brain Res. 2016;301:110–118.
   PubMed Web of Science ®Google Scholar
• Wilson SJ, Lipsey MW, Derzon JH. The effects of school-based intervention programs on aggressive behavior: a meta-analysis. J Consult Clin Psychol. 2003;71:136–149.
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care Excellence. 2015. Violence and aggression: short-term management in mental health, health and community settings. [cited 2017 Aug 10]. Available from: https://www.nice.org.uk/guidance/ng10/resources/violence-and-aggression-shortterm-management-in-mental-health-health-and-community-settings-1837264712389
   Google Scholar